Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

GWP.L (GWP) Regulatory News

Date Source Headline
30th Jun 2011 7:00 am RNS Second Phase III Pain Trial Commences
8th Jun 2011 5:01 pm RNS Director/PDMR Shareholding
8th Jun 2011 3:01 pm RNS Director/PDMR Shareholding
8th Jun 2011 7:00 am RNS Regulatory Approval
3rd Jun 2011 11:00 am RNS Director/PDMR Shareholding
26th May 2011 7:00 am RNS Regulatory Approval
18th May 2011 1:14 pm RNS Blocklisting Application
17th May 2011 7:00 am RNS Half Yearly Report
28th Apr 2011 7:00 am RNS Notice of Results - Amendment
27th Apr 2011 5:59 pm RNS Notice of Results
20th Apr 2011 7:00 am RNS US Patent Granted for Sativex in Cancer Pain
15th Apr 2011 7:00 am RNS Regulatory Approval
11th Apr 2011 7:00 am RNS Exclusive Licence Agreement Signed with Novartis
25th Mar 2011 4:40 pm RNS Second Price Monitoring Extn
25th Mar 2011 4:35 pm RNS Price Monitoring Extension
25th Mar 2011 4:15 pm RNS Director/PDMR Shareholding
22nd Mar 2011 7:00 am RNS Sativex Mutual Recognition Procedure Closes
15th Mar 2011 4:40 pm RNS Second Price Monitoring Extn
15th Mar 2011 4:35 pm RNS Price Monitoring Extension
14th Mar 2011 7:00 am RNS Sativex launched in Spain
2nd Mar 2011 7:00 am RNS Positive Sativex Study in MS Spasticity Published
22nd Feb 2011 8:23 am RNS Holding(s) in Company
17th Feb 2011 5:47 pm RNS Blocklisting Application
17th Feb 2011 5:46 pm RNS Blocklisting Interim Review
17th Feb 2011 5:42 pm RNS Issue of Equity
17th Feb 2011 7:00 am RNS Sativex granted reimbursement in Spain
9th Feb 2011 10:25 am RNS Director/PDMR Shareholding
19th Jan 2011 5:05 pm RNS AGM Resolutions passed
17th Jan 2011 7:00 am RNS Receipt of Milestone Payment
20th Dec 2010 9:29 am RNS Adviser - Change of Name
13th Dec 2010 4:15 pm RNS Director/PDMR Shareholding
9th Dec 2010 2:39 pm RNS Publication of Annual Report
8th Dec 2010 3:52 pm RNS Director/PDMR Shareholding
3rd Dec 2010 7:00 am RNS Change of Adviser
29th Nov 2010 4:31 pm RNS Director/PDMR Shareholding
23rd Nov 2010 7:01 am RNS Sativex Enters Phase III Cancer Pain Programme
23rd Nov 2010 7:00 am RNS Final Results
19th Nov 2010 10:10 am RNS Update on Nomad and Broker Position
3rd Nov 2010 7:00 am RNS Sativex Approved in New Zealand for MS Spasticity
21st Oct 2010 11:30 am RNS Notice of Results
FTSE 100 Latest
Value8,809.74
Change53.53